These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12397170)

  • 21. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 22. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study.
    Marchetti A; Magar R; Findley L; Larsen JP; Pirtosek Z; Růzicka E; Jech R; Sławek J; Ahmed F
    Mov Disord; 2005 Aug; 20(8):937-44. PubMed ID: 15810022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can I treat this pregnant patient with botulinum toxin?
    Pearce CS
    Pract Neurol; 2014 Feb; 14(1):32-3. PubMed ID: 24390703
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy.
    Thobois S; Broussolle E; Toureille L; Vial C
    Mov Disord; 2001 Jul; 16(4):764-5. PubMed ID: 11481708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with long-term treatment with albumin-supplemented botulinum toxin type A.
    Mohammadi B; Kollewe K; Wegener M; Bigalke H; Dengler R
    J Neural Transm (Vienna); 2009 Apr; 116(4):437-41. PubMed ID: 19319477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases.
    Grosset DG; Tyrrell EG; Grosset KA
    J Rehabil Med; 2015 Feb; 47(2):183-6. PubMed ID: 25325305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin A for the treatment of cervical dystonia.
    Zesiewicz TA; Stamey W; Sullivan KL; Hauser RA
    Expert Opin Pharmacother; 2004 Sep; 5(9):2017-24. PubMed ID: 15330738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia.
    Han Y; Stevens AL; Dashtipour K; Hauser RA; Mari Z
    J Neurol; 2016 Apr; 263(4):772-80. PubMed ID: 26914922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.
    Poewe W
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):430. PubMed ID: 11909897
    [No Abstract]   [Full Text] [Related]  

  • 31. Dysphagia after botulinum toxin injections for spasmodic torticollis: clinical and radiologic findings.
    Comella CL; Tanner CM; DeFoor-Hill L; Smith C
    Neurology; 1992 Jul; 42(7):1307-10. PubMed ID: 1620339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature.
    Gioltzoglou T; Cordivari C; Lee PJ; Hanna MG; Lees AJ
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1594-6. PubMed ID: 16227561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA.
    Hussar DA; Kaczinski J
    J Am Pharm Assoc (2003); 2010; 50(3):436-9. PubMed ID: 20452924
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ; Kilminster SG; Salt R
    Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical dystonia: from pathophysiology to pharmacotherapy.
    Patel S; Martino D
    Behav Neurol; 2013; 26(4):275-82. PubMed ID: 22713419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group.
    Poewe W; Deuschl G; Nebe A; Feifel E; Wissel J; Benecke R; Kessler KR; Ceballos-Baumann AO; Ohly A; Oertel W; Künig G
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):13-7. PubMed ID: 9436721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group.
    Kessler KR; Skutta M; Benecke R
    J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The finding and evaluation of EMG-guided BOTOX injection in cervical dystonia.
    Lee LH; Chang WN; Chang CS
    Acta Neurol Taiwan; 2004 Jun; 13(2):71-6. PubMed ID: 15478678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry.
    Trosch RM; Espay AJ; Truong D; Gil R; Singer C; LeWitt PA; Lew MF; Tagliati M; Adler CH; Chen JJ; Marchese D; Comella CL
    J Neurol Sci; 2017 May; 376():84-90. PubMed ID: 28431634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Do not say more Botox!].
    Junod V
    Rev Med Suisse; 2012 Feb; 8(326):288-9. PubMed ID: 22364079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.